• Fund Type: Open-End Fund
  • Objective: US
  • Asset Class: Equity
  • Geographic Focus: U.S.

Cullen Fund PLC - US Enhanced Equity Income Fund

+ Add to Watchlist

CNAUIBD:ID

11.01 USD 0.08 0.73%

As of 07:00:00 ET on 09/16/2014.

Snapshot for Cullen Fund PLC - US Enhanced Equity Income Fund (CNAUIBD)

Year To Date: +6.25% 3-Month: +0.83% 3-Year: - 52-Week Range: 9.97 - 11.16
1-Month: +1.76% 1-Year: +12.69% 5-Year: - Beta vs ISEQ: -

Mutual Fund Chart for CNAUIBD

No chart data available.
  • CNAUIBD:ID 11.01
  • 1M
  • 1Y
Interactive CNAUIBD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CNAUIBD

Cullen Fund PLC - US Enhanced Equity Income Fund is an open-end fund incorporated in Ireland. The Fund's objective is to seek long-term capital appreciation and current income. The Fund will invest in dividend paying securities from medium to large companies that have below average price/earning ratios and above average dividend yield compared with the S&P 500 Stock Index.

Inception Date: 06-04-2013 Telephone: -
Managers: -
Web Site: -

Fundamentals for CNAUIBD

NAV (on 2014-09-16) 11.01
Assets (M) (on 2014-09-16) 5.09
Fund Leveraged N
Minimum Investment 1,000,000.00
Minimum Subsequent Investment 100,000.00

Dividends for CNAUIBD

Dividend Type Income
Dividend Frequency Irreg
Last Dividend Net (on 2014-07-01) 0.16
Dividend Yield (ttm) 4.41

Fees & Expenses for CNAUIBD

Front Load -
Back Load -
Current Mgmt Fee 0.75
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for CNAUIBD

Filing Date: 08/29/2014
Name Position Value % of Total
Microsoft Corp 5,200 236,236 3.315%
Johnson & Johnson 2,200 228,206 3.202%
Unilever NV 5,450 226,938 3.185%
Merck & Co Inc 3,650 219,402 3.079%
Wells Fargo & Co 4,200 216,048 3.032%
Altria Group Inc 5,000 215,400 3.023%
JPMorgan Chase & Co 3,590 213,426 2.995%
Chevron Corp 1,640 212,298 2.979%
Novartis AG 2,300 206,632 2.900%
GlaxoSmithKline PLC 4,200 206,220 2.894%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil